Bio

Dr. Hossein Sharifi is a urologic surgeon specializing in urologic oncology and minimally invasive surgery. He has extensive clinical experience in the diagnosis and surgical management of cancers of the prostate, kidney, bladder, testis, and other genitourinary organs.

Prior to joining LSU Health New Orleans, Dr. Sharifi completed advanced fellowship training in Minimally Invasive Urology at the Medical University of South Carolina and in Urologic Oncology at the University of Miami. His training and clinical practice have focused on advanced laparoscopic, endoscopic, and robotic surgical techniques for complex urologic diseases.

His clinical practice focuses on comprehensive management of genitourinary cancers, with particular interests in prostate, bladder, and kidney cancer. He has expertise in robotic and minimally invasive urologic oncology surgery and advanced prostate cancer diagnostics, including Transperineal prostate biopsy and MRI-targeted biopsy.

Dr. Sharifi is also actively involved in clinical and translational research. He has authored 37 peer-reviewed publications and has presented his research at national and international meetings. His research interests include prostate cancer diagnosis and active surveillance, MRI-targeted and Transperineal prostate biopsy, bladder cancer, minimally invasive and robotic surgery, and development of novel technologies in urology.

Clinical Interests

Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Robotic and Minimally Invasive Urologic Surgery
Advanced Prostate Cancer Diagnostics
Transperineal Prostate Biopsy
MRI-Targeted Prostate Biopsy
Endourology

Research Interests

Prostate Cancer Diagnosis and Active Surveillance
MRI-Targeted and Transperineal Prostate Biopsy
Optimization of Prostate Biopsy Strategies
Urologic Oncology Outcomes
Robotic and Minimally Invasive Surgery
Novel Technologies and Translational Research in Urology

His translational research includes the development of novel drug-delivery technologies for the urinary tract. He developed and patented a catheter designed for electromotive drug administration (EMDA), a technique that uses a low electrical current to enhance local drug penetration, in the upper urinary tract.  U.S. Patent No.: 12,544,567 (US12544567B2)